ProShares Ultra Nasdaq Biotechnology
(NASDAQ:BIB)
$48.22
-0.73[-1.49%]
Last update: 3:14PM Get Real Time Here
OverviewNewsDividendsShort Interest

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), Quotes and News Summary

ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB) stock price, news, charts, stock research, profile.

Open$49.000
Close-
Volume / Avg.9.650K / 40.725K
Day Range48.197 - 49.000
52 Wk Range40.100 - 62.450
Market Cap-
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
28
Short Interest-
Days to Cover1

Recent News

Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective as of market open on Mon
Nina Zdinjak
3 ETFs To Watch Out For On Biotech Earnings
Exclusive: SunTrust Managing Director Goes Over Sarepta Therapeutics' Story

FAQ

Q

How do I buy ProShares Ultra Nasdaq Biotechnology (BIB) stock?

A

You can purchase shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are ProShares Ultra Nasdaq Biotechnology's (BIB) competitors?

A

There are no as such competitors for ProShares Ultra Nasdaq Biotechnology.

Q

What is the target price for ProShares Ultra Nasdaq Biotechnology (BIB) stock?

A

There is no analysis for ProShares Ultra Nasdaq Biotechnology.

Q

Current Stock Price for ProShares Ultra Nasdaq Biotechnology (BIB)?

A

The stock price for ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB) is $50 last updated April 16, 2024 at 9:16 AM EDT.

Q

Does ProShares Ultra Nasdaq Biotechnology (BIB) pay a dividend?

A

A quarterly cash dividend of $0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on September 28, 2010 to stockholders of record on September 21, 2010.

Q

When is ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) reporting earnings?

A

ProShares Ultra Nasdaq Biotechnology does not have any upcoming earnings scheduled.

Q

Is ProShares Ultra Nasdaq Biotechnology (BIB) going to split?

A

There is no upcoming split for ProShares Ultra Nasdaq Biotechnology.